FDA Approvals in Oncology: January-March 2026
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Tag: Lung cancer
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
What does a naked mole rat, a nuclear exporter that “moonlights” as a chromatin regulator, and the combined power...
Cancer Today's winter 2025-2026 issue covers delaying stem cell transplants in multiple myeloma, new treatments for brain metastases, and...
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
In November, the AACR’s journal editors highlighted studies on sucralose limiting immunotherapy, benefits of caloric restriction, and more.
The FDA is proposing a cap on nicotine in cigarettes that would reduce the amount by 95%, which could...
In October 2025, AACR's journals editors highlighted studies on the anticancer function of an Alzheimer’s-related protein, small-molecule-drug conjugates, and...
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
For August 2025, the editors of AACR's journals highlighted studies on liquid biopsy for brain cancer, new treatment strategies...
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.